Home
Site Map
Contact us
Québec Portal
Media Relations
Employment
Français
INESSS Express
Restricted access
Quick menu
Abonnement à l'INESSS Express
Abonnement aux veilles de l'INESSS
Cancerology Algorithms
Consult publications
Emplois
Drug products
Optimal use guides
Knowledge transfert tools
Medical protocols and related prescriptions
COVID-19
Risques d’hospitalisation et projections des besoins hospitaliers
Traitements spécifiques à la COVID-19
Affections post-COVID-19 (COVID longue)
Alternatives de traitements en contexte de pandémie
Autres traitements
Cancérologie
Études cliniques en cours - Prophylaxie et traitement
Ordonnances collectives
Regard sur la pandémie COVID-19 au Québec
Présentations cliniques
Investigation - Procédures diagnostiques
Rétablissement et reprise des activités
Services sociaux
Méthode de réponse rapide - COVID-19
Contributions des UETMIS
Sites d'intérêt
About Us
About the Institut
Get Involved
Board of Directors
Advisory panel
Scientific Council
Structure
Networks and partnerships
Team
Administrative documents
Employment
INESSS Alerts
Stage
Démarche
Démarche
Themes
Drug Products
Optimal use of medication
Medical protocols and related prescriptions
Medical Biology Procedures
Cancerology
Cardiology and neurovascular disease
Screening and preventive practices
Medical imagery
Innovations non pharmaceutiques
Modes d'intervention en santé
Blood system products
Critical care
Cellular Therapy Evaluation
Traumatology
Physical and intellectual disabilities and Autism Spectrum Disorder (ASD)
Addiction and homelessness
Troubled youth
Support for seniors’ autonomy
Mental health
General social services
Publications
Publications
Algorithms in Oncology
Order a publication
INESSS's Guides
Projects
On-going projects
Quality Indicators: Managing Chronic Diseases
Formations and Knowledge transfer
Our Tools
Formations and other activities
Knowledge transfer
Nous joindre
Portail Québec
Salle de presse
Emplois
INESSS Express
Restricted access
Projet pilote sur l'évaluation de quatre médicaments anticancéreux
11-23-2011
|
Cancérologie
REF220
Subscribe to our newsletter now
Subscription
